Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Korean Med Sci. 2013 Jul;28(7):1107-10. doi: 10.3346/jkms.2013.28.7.1107. Epub 2013 Jul 3.
Osteogenesis imperfecta (OI) comprises a heterogeneous group of disorders characterized by bone fragility, frequent fractures, and low bone mass. Dominantly inherited COL1A1 or COL1A2 mutations appear to be causative in the majority of OI types, but rare recessively inherited genes have also been reported. Recently, SERPINF1 has been reported as another causative gene in OI type VI. To date, only eight SERPINF1 mutations have been reported and all are homozygous. Our patient showed no abnormalities at birth, frequent fractures, osteopenia, and poor response on pamidronate therapy. At the time of her most recent evaluation, she was 8 yr old, and could not walk independently due to frequent lower-extremity fractures, resulting in severe deformity. No clinical signs were seen of hearing impairment, blue sclera, or dentinogenesis imperfecta. In this study, we describe the clinical and radiological findings of one Korean patient with novel compound heterozygous mutations (c.77dupC and c.421dupC) of SERPINF1.
成骨不全症(OI)是一组以骨骼脆弱、频繁骨折和低骨量为特征的异质性疾病。大多数 OI 类型似乎与 COL1A1 或 COL1A2 突变的显性遗传有关,但也有报道罕见的隐性遗传基因。最近,SERPINF1 被报道为 OI 六型的另一个致病基因。迄今为止,仅报道了 8 种 SERPINF1 突变,均为纯合子。我们的患者出生时无异常,频繁骨折,骨质疏松,帕米膦酸盐治疗反应不佳。在最近一次评估时,她 8 岁,由于下肢频繁骨折导致严重畸形,无法独立行走。没有听力损伤、蓝巩膜或牙本质生成不全的临床体征。在这项研究中,我们描述了一位韩国患者的临床和影像学发现,该患者存在 SERPINF1 的新型复合杂合突变(c.77dupC 和 c.421dupC)。